NovaBridge Biosciences (NASDAQ:NBP) showed up in the 13F filings of 57 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Dec, 2025 | 8,436,641 | 445,264 | 5.57% | $33,577,831.00 |
| HHLR ADVISORS, LTD. | 31 Dec, 2025 | 5,980,568 | 0 | 0.00% | $23,802,661.00 |
| Morgan Stanley | 31 Dec, 2025 | 3,785,502 | 1,553,462 | 69.60% | $15,066,298.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 3,000,000 | 1,834,043 | 157.30% | $11,940,000.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 2,298,501 | 2,221,153 | 2,871.64% | $9,148,034.00 |
| Ariose Capital Management Ltd | 31 Dec, 2025 | 1,363,515 | -340,878 | -20.00% | $5,426,790.00 |
| Candriam S.C.A. | 31 Dec, 2025 | 1,132,563 | 0 | 0.00% | $4,507,793.00 |
| Woodline Partners LP | 31 Dec, 2025 | 1,050,000 | 0 | 0.00% | $4,179,000.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Dec, 2025 | 1,000,000 | -2,338,034 | -70.04% | $3,980,000.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 846,008 | 823,555 | 3,667.91% | $3,367,112.00 |
| Barclays Plc | 31 Dec, 2025 | 628,923 | -192,309 | -23.42% | $2,503,113.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 618,347 | 618,347 | 0.00% | $2,461,021.00 |
| Exome Asset Management LLC | 31 Dec, 2025 | 499,587 | -940,017 | -65.30% | $1,988,356.00 |
| AIHC Capital Management Ltd | 31 Dec, 2025 | 413,979 | 413,979 | 0.00% | $1,647,636.00 |
| State Street Corp | 31 Dec, 2025 | 359,878 | 22,478 | 6.66% | $1,432,314.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 281,892 | 63,422 | 29.03% | $1,121,930.00 |
| Connor, Clark & Lunn Investment Management Ltd. | 31 Dec, 2025 | 191,714 | 27,650 | 16.85% | $763,022.00 |
| UBS Group AG | 31 Dec, 2025 | 181,776 | -113,302 | -38.40% | $723,468.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 148,452 | 49,676 | 50.29% | $590,839.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 140,867 | 140,867 | 0.00% | $560,651.00 |